Cargando…

Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells

Cancer-associated fibroblasts (CAFs) promote tumor growth and progression, and increase drug resistance through several mechanisms. We have investigated the effect of CAFs on the p53 response to doxorubicin in prostate cancer cells. We show that CAFs produce interleukin-6 (IL-6), and that IL-6 atten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheteh, Emarndeena H., Sarne, Victoria, Ceder, Sophia, Bianchi, Julie, Augsten, Martin, Rundqvist, Helene, Egevad, Lars, Östman, Arne, Wiman, Klas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265343/ https://www.ncbi.nlm.nih.gov/pubmed/32528731 http://dx.doi.org/10.1038/s41420-020-0272-5

Ejemplares similares

Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
por: Cheteh, Emarndeena H, et al.
Publicado: (2017)

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2021)

Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2022)

p53 as a hub in cellular redox regulation and therapeutic target in cancer
por: Eriksson, Sofi E, et al.
Publicado: (2019)

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
por: Ceder, Sophia, et al.
Publicado: (2020)

Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis
por: Strell, Carina, et al.
Publicado: (2012)

Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy
por: Bykov, Vladimir J. N., et al.
Publicado: (2016)

Effect of Acute Exercise on Prostate Cancer Cell Growth
por: Rundqvist, Helene, et al.
Publicado: (2013)

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
por: Kharaziha, P, et al.
Publicado: (2012)

Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth
por: Alexeyenko, Andrey, et al.
Publicado: (2015)

Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts
por: Mancilla, T. R., et al.
Publicado: (2020)

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
por: Fransson, Åsa, et al.
Publicado: (2016)

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2018)

The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells
por: Synnott, Naoise C., et al.
Publicado: (2018)

Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246
por: Haffo, Lena, et al.
Publicado: (2018)

Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2019)

T026: Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma
por: Karihtala, Kristiina, et al.
Publicado: (2022)

PRIMA-1(MET) Inhibits Growth of Mouse Tumors Carrying Mutant p53
por: Zache, Nicole, et al.
Publicado: (2008)

CRY2 Is Associated with Rapid Cycling in Bipolar Disorder Patients
por: Sjöholm, Louise K., et al.
Publicado: (2010)

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)

Fibroblast as a critical stromal cell type determining prognosis in prostate cancer
por: Blom, Sami, et al.
Publicado: (2019)

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
por: Sjöberg, Elin, et al.
Publicado: (2018)

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
por: Mezheyeuski, Artur, et al.
Publicado: (2020)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
por: Mohell, N, et al.
Publicado: (2015)

Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
por: Zhang, Meiqiongzi, et al.
Publicado: (2018)

WRAP53 Is Essential for Cajal Body Formation and for Targeting the Survival of Motor Neuron Complex to Cajal Bodies
por: Mahmoudi, Salah, et al.
Publicado: (2010)

Correction: WRAP53 Is Essential for Cajal Body Formation and for Targeting the Survival of Motor Neuron Complex to Cajal Bodies
por: Mahmoudi, Salah, et al.
Publicado: (2018)

Mutant p53 targeting by the low molecular weight compound STIMA‐1
por: Zache, Nicole, et al.
Publicado: (2017)

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer
por: Herrera, Mercedes, et al.
Publicado: (2020)

Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog
por: Zhang, Qiang, et al.
Publicado: (2022)

Interleukin-8 released by cancer-associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells
por: Thongchot, Suyanee, et al.
Publicado: (2021)

Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
por: Hiensch, Anouk E., et al.
Publicado: (2019)

Inhibiting the system x(C)(−)/glutathione axis selectively targets cancers with mutant-p53 accumulation
por: Liu, David S., et al.
Publicado: (2017)

N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells
por: BRUM, GABRIELLA, et al.
Publicado: (2012)

Cytotoxic T-cells mediate exercise-induced reductions in tumor growth
por: Rundqvist, Helene, et al.
Publicado: (2020)

Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
por: Augsten, Martin
Publicado: (2014)

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0r1utj5spfk9vj1s9dn6g7fgs9